05.06.20
In the first quarter of 2020, Ontex’s reported revenue was up 5.1% to €574.2 million ($624 million).
Babycare category revenue recorded a strong growth in Q1 2020, up by 7.3% to €328.3 million ($356.7 million) versus a year ago. Sales of baby diapers and baby pants were both well above the comparable period in 2019. This was the case for the retailers brands the company supplies to leading retailers across Europe and increasingly in the U.S., as well as for its own portfolio of local brands in AMEAA.
Revenue in the Adult Incontinence (Adult Inco) category was up 3.4% to €177.1 million ($192.4 million) in Q1 2020. Sales growth was posted in the main product types, including a solid increase in adult pants. Adult Inco revenue in retail channels was 11% higher, thanks to higher sales of Ontex brands in AMEAA and retailer brands in Europe. Sales in institutional channels were slightly lower as expected, due to a temporary suspension of a supply contract from October 2019 until March 2020, which has now fully resumed since April 2020.
Q1 2020 Feminine Care category (Femcare) revenue increased strongly, up 14.7% to €62 million ($67.4 million) compared with a year ago. Higher sales were posted both in Europe, where the majority of our revenue is generated, as well as in AMEAA, which saw continued strong demand for products such as organic cotton tampons.
Babycare category revenue recorded a strong growth in Q1 2020, up by 7.3% to €328.3 million ($356.7 million) versus a year ago. Sales of baby diapers and baby pants were both well above the comparable period in 2019. This was the case for the retailers brands the company supplies to leading retailers across Europe and increasingly in the U.S., as well as for its own portfolio of local brands in AMEAA.
Revenue in the Adult Incontinence (Adult Inco) category was up 3.4% to €177.1 million ($192.4 million) in Q1 2020. Sales growth was posted in the main product types, including a solid increase in adult pants. Adult Inco revenue in retail channels was 11% higher, thanks to higher sales of Ontex brands in AMEAA and retailer brands in Europe. Sales in institutional channels were slightly lower as expected, due to a temporary suspension of a supply contract from October 2019 until March 2020, which has now fully resumed since April 2020.
Q1 2020 Feminine Care category (Femcare) revenue increased strongly, up 14.7% to €62 million ($67.4 million) compared with a year ago. Higher sales were posted both in Europe, where the majority of our revenue is generated, as well as in AMEAA, which saw continued strong demand for products such as organic cotton tampons.
